← Back to all media
The Ian Cowie portfolio: a healthy return on this investment
"This underlines the important point for long-term investors that, even after the coronavirus crisis has passed, the global population is likely to become gradually older and wealthier, with a corresponding increase in demand and the ability to pay for improved biotechnology and healthcare. In the meantime, most unusually for this sector, IBT yields 3.75% which pays shareholders to be patient."
Published on 7th May 2020